Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

Abroad (travel likely)RecruitingPHASE4

Conditions

Renal Cell Cancer · Kidney Neoplasm · Immunotherapy · Kidney Cancer · Surgery Programmed · Radiotherapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy

Study leads

Roberto Iacovelli, M.D.; Ph.D.
Principal Investigator
Catholic University of Rome, Italy

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Solid Tumor, Adult · Colorectal Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)Recruiting

Gilbert, United States · Phoenix, United States

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

Neoplasms · Kidney Neoplasms · Urologic Neoplasms

Abroad (travel likely)Recruiting

Nanjing, China

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma · Metastatic Renal Cell Carcinoma · Stage IV Renal Cell Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Gilbert, United States

Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer

Renal Tumor Histology · Cutaneous Leiomyoma · Kidney Cancer

Abroad (travel likely)Recruiting

Bethesda, United States